A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2011
10/06/2011	WO2011122620A1 Pharmaceutical preparation comprising phenylalanine derivative
10/06/2011	WO2011122619A1 Phenylalanine derivative salt crystal
10/06/2011	WO2011122611A1 Cancer vaccine
10/06/2011	WO2011122318A1 Therapeutic graft material and method for using same
10/06/2011	WO2011121062A1 Composition for the treatment of periodontitis and other inflammatory infectious diseases
10/06/2011	WO2011120707A1 Compositions for dental treatment comprising lipoteichoic acids or parts thereof like mono- or polyglycerphosphates
10/06/2011	WO2011053917A3 Gastroretentive oral high dose zinc preparations
10/06/2011	WO2011037349A3 Target specific drug delivery system, target non-specific long-acting drug delivery system and method of controlling target specificity thereof
10/06/2011	US20110245339 Prodrugs of short-chain fatty acids and treatment methods
10/06/2011	US20110245322 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
10/06/2011	US20110245316 Prevention or delay of onset of oral mucositis
10/06/2011	US20110245308 Substituted benzyl and phenylsulfonyl triazolones, and use thereof
10/06/2011	US20110245303 Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
10/06/2011	US20110245291 Tricyclic delta-opioid modulators
10/06/2011	US20110245267 Piperidine and piperazine derivatives and methods of use thereof
10/06/2011	US20110245257 Heterocyclic compounds and their uses
10/06/2011	US20110245250 Potassium ion channel modulators & uses thereof
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245245 Methods of treatment comprising the administration of heteroaryl compounds
10/06/2011	US20110245233 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
10/06/2011	US20110245230 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245223 Heterocyclic compounds
10/06/2011	US20110245209 Pyridopyrimidine derivatives and methods of use thereof
10/06/2011	US20110245208 Compositions and methods for the treatment of somatosensory disorders
10/06/2011	US20110245204 Cycloalkane-containing sphingosine 1-phosphate agonists
10/06/2011	US20110245199 Sulfated Depolymerized Derivatives of Expolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing the Same, and Uses Thereof in Tissue Regeneration
10/06/2011	US20110245197 Hypersulfated glucopyranosides
10/06/2011	US20110245187 Mesenchymal cell proliferation promoter and skeletal system biomaterial
10/06/2011	US20110245172 Biocompatible oligomer-polymer compositions
10/06/2011	US20110245171 Rehydration compositions comprising epidermal growth factor (egf)
10/06/2011	US20110245159 Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same
10/06/2011	US20110245158 High Protein Supplement
10/06/2011	US20110244574 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/06/2011	US20110244059 Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitor
10/06/2011	US20110244035 Dosage Forms
10/06/2011	US20110244027 2'-Fluoro-6'-Methylene Carbocyclic Nucleosides and Methods of Treating Viral Infections
10/06/2011	US20110244026 Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
10/06/2011	US20110243991 Process for production of vaccines
10/06/2011	US20110243963 Antibodies to lrp6
10/06/2011	US20110243955 Antibody and uses thereof
10/06/2011	US20110243943 Treatment using relaxin-fusion proteins with extended in vivo half-lives
10/06/2011	US20110243940 Bicyclic pyranone derivatives and methods of use thereof
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243928 Chimeric and humanised monoclonal antibodies against interleukin-13
10/06/2011	US20110243924 Novel methods
10/06/2011	US20110243923 Organic compounds
10/06/2011	US20110243900 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
10/06/2011	US20110243895 Generation of patient-specific differentiated cell types by epigenetic induction
10/06/2011	US20110243890 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus
10/06/2011	US20110243889 Opioid and opioid-like compounds and uses thereof
10/06/2011	US20110243881 Biocompatible polymers, process for their preparation and compositions containing them
10/06/2011	US20110243879 Methods of treating hepatic encephalopathy
10/06/2011	US20110243845 Somatostatin analogs with inhibitory activity to growth hormone release
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	US20110240512 Antibiotic Formulations Providing Reduced Gastrointestinal Side Effects and Clostridium difficile Infection Relapse, and Related Methods
10/06/2011	CA2795043A1 Humanized il-25 antibodies
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371839A1 Peptidomimetic protease inhibitors
10/05/2011	EP2371394A1 Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
10/05/2011	EP2371393A1 Preventive or remedy for inflammatory disease
10/05/2011	EP2371379A2 New formulation for increasing bioavailability of neurturin
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	EP2371355A2 Preparations of phospholipids and pharmaceuticals containing-5-amino salicyclic acid for the treatment of inflammatory bowel disease
10/05/2011	EP2370069A1 Antioxidant compositions for soft oral tissue and methods of formulation and use there
10/05/2011	EP2040724B1 Biotherapeutic compositions comprising probiotic escherichia coli and metronidazole and uses thereof
10/05/2011	EP1986651B1 Use of a pyrimidinedione derivative for preventing or treating hepatitis c
10/05/2011	EP1885390B1 Use of peptides derived from the growth factor amp-18 for the treatment of oral mucositis
10/05/2011	EP1855550B1 Nutritional composition with probiotics
10/05/2011	EP1825856B1 Oral composition containing difructose anhydride
10/05/2011	EP1787991B1 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
10/05/2011	EP1377276B1 Timed pulse release composition
10/05/2011	CN1990006B Chenopodium ambrosioides extract, preparation thereof, preparation method and use thereof
10/05/2011	CN1732934B Freeze dry betahistine hydrochloride injection and method for preparing the same
10/05/2011	CN102209719A Novel prostaglandin i2 derivative
10/05/2011	CN102209549A Use of ammonium chloride in therapy
10/05/2011	CN102209529A Method for delivering a pharmaceutical composition to patient in need thereof
10/05/2011	CN102206289A Extraction process for polysaccharide from Bassia rapa L.
10/05/2011	CN102206277A Antibodies that bind human interleukin-18 and methods of making and using
10/05/2011	CN102205122A Method for preparing piglet diarrhea-resisting egg yolk antibody microcapsules by spray drying method
10/05/2011	CN102205115A Application of ulinastatin serving as rescue auxiliary medicament for toxic shock caused by acute abdomen
10/05/2011	CN102205108A Traditional Chinese medicine preparation for treating gastric ulcer and preparation method thereof
10/05/2011	CN102205107A Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof
10/05/2011	CN102205105A Traditional Chinese medicine composition for treating chronic colitis
10/05/2011	CN102205098A Chinese medicinal herb composition for treating chronic enteritis
10/05/2011	CN102205090A Chinese medicinal stagnancy-removing and stagnation-eliminating soup for treating liver depression qi stagnation type indigestion
10/05/2011	CN102205087A Chinese medicinal composition for treating chronic gastritis and preparation method thereof
10/05/2011	CN102205086A Chinese medicinal composition for treating gastric and duodenal ulcer and preparation method thereof
10/05/2011	CN102205085A Anti-ulcer tablet for treating stomach disease
10/05/2011	CN102205084A Traditional Chinese medicine preparation for treating functional dyspepsia of spleen deficiency type
10/05/2011	CN102205068A Medicament for treating chronic ulcerative colitis and preparation method thereof
10/05/2011	CN102205034A Preparation method of Chinese medicine for treating diarrhea infantile influenza
10/05/2011	CN102205027A Medicated wine capable of tonifying kidney and yang and preparation method thereof
10/05/2011	CN102204999A Method for measuring content of luteolin in callicarpa nudiflora preparation
10/05/2011	CN102204995A Kidney-reinforcing tonic wine
10/05/2011	CN102204993A Chuang medical granule for treating virus B hepatitis and preparation method thereof
10/05/2011	CN102204980A Wuji (liver-fire-purging and spleen-stomach-regulating) gastric stasis preparation and preparation method thereof
10/05/2011	CN102204979A Medicinal composition for treating children gastritis and preparation method thereof
10/05/2011	CN102204975A Medicinal composition for treating acute and chronic enteritis
10/05/2011	CN102204971A Traditional Chinese medicine preparation for preventing and treating stomatopathy and throat diseases

1 ... 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 ... 1258